Is the "new crown drug concept" still rising? Xinhua Pharmaceutical, China Resources Shuanghe reminded risks, Aoxiang Pharmaceutical fell to the limit after two consecutive boards. Interface News · Securities

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000632 000756 300227 300452 300585 300713 Anhui Sunhere Pharmaceutical Excipients China Resources Double-Crane Pharmaceutical China Shipbuilding Industry Group Power Citic Securities Fujian Funeng Fujian Sanmu Group Nanjing Aolian Ae&Ea Shandong Xinhua Pharmaceutical Company Limited Shenzhen Sunshine Laser&Electronics Technology Shenzhenrease Technology Xinjiang Sayram Modern Agriculture Zhejiang Ausun Pharmaceutical Regulations Management Strategy, Marketing Research, Development Pharmaceutical Electricity Production, Distribution Automotive International Trade Market, Exchange Securities University Aids Medicine Club, Association Food, Drink Enthusiasm Food, Drink Regulations Biotechnology Small, Medium Enterprise Cooperative Economy, Business, Finance Environment

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Is the "new crown drug concept" still rising? Xinhua Pharmaceutical, China Resources Shuanghe reminded risks, Aoxiang Pharmaceutical fell to the limit after two consecutive boards. Interface News · Securities